MedTrace Logo

FDA: Lowering Orthopedic Opioid Dosing (FLOOD)

NCT02576392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 561

Last updated 2017-06-06

No results posted yet for this study

Summary

This randomized trial evaluates an intervention to minimize use of opioids following total hip and total knee replacement. Half the participants will receive an intervention (mailed educational materials, followed by a pharmacist call), and half will receive usual care.

Conditions

  • Post-operative Pain

Interventions

BEHAVIORAL

Intervention

Intervention consisted of a mailing 2 weeks prior to surgery, another 2 weeks post surgery, and a pharmacist intervention if a refill of opioid medication was requested within 90 days of surgery.

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • David H Smith, RPh, PhD · Kaiser Permanente NW

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2017-03-31
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576392 on ClinicalTrials.gov